Paragonix SherpaPak™ Cardiac Transport System to Be Featured in Clinical Presentation at 2019 American Transplant Congress

Paragonix
Technologies, Inc. today announced that the Paragonix SherpaPak™
Cardiac Transport System (CTS), the industry’s only FDA cleared and CE
marked system for donor organ heart transport and storage, will be
featured in a clinical presentation at the 2019
American Transplant Congress. The meeting is being held June 1-5,
2019 in Boston.

Dr. Julia Dumfarth, PhD, Chief of Heart Transplantation, Department of
Cardiac Surgery, at the Medical University Innsbruck (Innsbruck,
Austria) will present, “First
Experience for Cold Storage of Donor Hearts with Paragonix SherpaPak.”

• Sunday, June 2, 2019, Poster Session B: Heart and VADs: All Topics
• Session Time: 6:00-7:00pm
• Presentation Time: 6:00-7:00pm
• Location: Hall C & D

Preservation of donor organs is a crucial component for the maintenance
of viability during the journey from donor to recipient patient. The
current standard for transporting a donor organ includes the storage in
preservation solution within sequential plastic bags that are placed in
a cooler containing ice. A potential issue associated with this method
of storage is a too low temperature leading to tissue injury. Paragonix
has developed an organ preservation system that keeps organs at a stable
temperature. Dr. Dumfarth will provide an overview of a clinical case in
which the Paragonix SherpaPak™ CTS was applied safely and easily,
preventing the donor organ from cold injury.

“The number of clinical reports on how Paragonix SherpaPak™ CTS is
transforming donor heart preservation is rapidly increasing and we are
delighted about the positive impact Paragonix SherpaPak™ CTS has made
for donor heart recovery teams, implanting surgeons and patients,” said
Bill Edelman, Chairman and CEO of Paragonix Technologies.

Paragonix will be at booth #822, providing hands-on demonstrations of
the Paragonix SherpaPak™ CTS.

The Paragonix
SherpaPak™ CTS has been used by heart transplant centers in both the
United States and Europe. The device is currently marketed in the United
States, United Kingdom, France, Spain, Italy, Germany, Austria, Sweden
and Slovak Republic in Europe.

About the American Transplant Congress
The American
Transplant Congress is the Joint Annual Meeting of the American
Society of Transplant Surgeons (ASTS) and the American
Society of Transplantation (AST). ATC provides a forum for exchange
of new scientific and clinical information relevant to solid organ and
tissue transplantation and brings together transplant physicians,
scientists, nurses, organ procurement personnel, pharmacists, allied
health professionals and other transplant professionals. The educational
offerings provide attendees the opportunity to learn cutting-edge
advances in research and exchange of ideas and practice in the field of
solid organ and tissue transplantation.

About the University of Innsbruck
The University of
Innsbruck is a public university in Innsbruck, the capital of the
Austrian federal state of Tyrol, founded in 1669. It is currently the
largest education facility in the Austrian Bundesland of Tirol, the
third largest in Austria behind Vienna University and the University of
Graz and according to The Times Higher Education Supplement World
Ranking 2010 Austria's leading university. Significant contributions
have been made in many branches, most of all in the physics department.
Further, regarding the number of Web of Science-listed publications, it
occupies the third rank worldwide in the area of mountain research.

About the Paragonix SherpaPak™ Cardiac Transport System
The
Paragonix SherpaPak™ Cardiac Transport System (CTS) safeguards hearts
during the journey from donor to recipient patient. Our device
incorporates clinically proven and medically trusted cold preservation
techniques in a novel suspension system to provide unprecedented
physical and thermal protection. Paragonix SherpaPak™ CTS is the only
commercially available FDA cleared and CE marked medical device for
heart transportation.

About Paragonix Technologies, Inc.
Paragonix Technologies
markets organ transportation devices that safeguard organs during the
journey between donor and recipient patients. Our devices incorporate
clinically proven and medically trusted cold preservation techniques in
a novel suspension system to provide unprecedented physical and thermal
protection. Paragonix SherpaPak™ CTS is the only commercially available
FDA cleared and CE marked transport device for heart transportation.
Paragonix is also developing transport devices for the lung and kidneys
designed to improve donor organ quality and extending donor organ
transport time.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190530005117/en/